Verdiva Bio
London
About Verdiva Bio
Verdiva Bio is a company creating cutting-edge treatments that improve results for patients with obesity, cardiometabolic diseases, and associated problems by making treatment options more patient-friendly. Verdiva Bio operates in the cardiometabolic health sector, creating innovative treatments designed to improve the quality of care for patients facing these health issues.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $411.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: verdivabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/verdiva-bio-48738 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.